KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Debt to Equity (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Debt to Equity for 17 consecutive years, with $0.79 as the latest value for Q4 2025.

  • Quarterly Debt to Equity fell 14.2% to $0.79 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.79 through Dec 2025, down 14.2% year-over-year, with the annual reading at $0.79 for FY2025, 14.2% down from the prior year.
  • Debt to Equity hit $0.79 in Q4 2025 for Quest Diagnostics, up from $0.78 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.92 in Q4 2024 to a low of $0.59 in Q1 2021.
  • Historically, Debt to Equity has averaged $0.71 across 5 years, with a median of $0.67 in 2022.
  • Biggest five-year swings in Debt to Equity: decreased 16.51% in 2021 and later surged 38.96% in 2024.
  • Year by year, Debt to Equity stood at $0.62 in 2021, then increased by 8.45% to $0.67 in 2022, then rose by 10.72% to $0.74 in 2023, then increased by 23.43% to $0.92 in 2024, then dropped by 14.2% to $0.79 in 2025.
  • Business Quant data shows Debt to Equity for DGX at $0.79 in Q4 2025, $0.78 in Q3 2025, and $0.78 in Q2 2025.